# A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects

> **NCT04973735** · PHASE1 · UNKNOWN · sponsor: **Luye Pharma Group Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** LY-CovMab

## Key facts

- **NCT ID:** NCT04973735
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-10
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-07-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973735, "A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04973735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*